Changes in the enzymatic activities of beagle liver during maturation as assessed both in vitro and in vivo

References

• ABEI, M., TANAKA, E., TANAKA, N., MATSUZAKI, Y., IKEGAMI, T., ISHIKAWA, A. and OSUGA, T., 1995, Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. Journal of Gastroenterology, 30, 478–484.
   PubMed Web of Science ®Google Scholar
• AL-DAHHAN, J., HAYCOCK, G. B., CHANTLER, C. and STIMMLER, L., 1983, Sodium homeostasis in term and preterm neonates. I. Renal aspects. Archives of Disease in Childhood, 58, 335–42.
   Google Scholar
• CARRIER, O., PONS, G., REY, E., RICHARD, M.-0., MORAN, C., BADOUAL, J. and OLIVE, G., 1988, Maturation of caffeine metabolic pathways in infancy. Clinical Pharmacology and Therapeutics, 44, 145–151.
   Google Scholar
• CAZENEUVE, C., PONS, G., REY, E., TRELUYER, J.-M., CRESTEIL, T., THIROUX, G., D'ATHIS, P. and OLIVE, G., 1994, Biotranceformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults. British Journal of Clinical Pharmacology, 37, 405–412.
   Google Scholar
• CHENGELIS, C. P., 1988, Age- and sex-related changes in the components of the hepatic microsomal mixed function oxisase system in Sprague-Dawley rats. Xenobiotica, 18, 1211–1224.
   PubMed Web of Science ®Google Scholar
• CiAccio, P. J. and HALPERT, J. R., 1989, Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally relater to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily. Archives of Biochemistry and Biophysics, 271, 284–289.
   PubMed Web of Science ®Google Scholar
• CROM, W. R., 1994, Pharmacokinetics in the child. Environmental Health Perspectives, 102 (suppl. 11), 111–118.
   PubMed Web of Science ®Google Scholar
• DOECKE, C. J., SANSOM, L. N. and McMANus, M. E., 1990, Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes. Biochemical and Biophysical Research Communications, 166, 860–866.
   PubMed Web of Science ®Google Scholar
• EGUCHI, K., NISHIBE, Y., BABA, T. and OHNO, K., 1996, Quantification of cytochrome P450 enzymes (CYP1A1/2,2B11,2C21 and 3Al2) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica, 26, 755–764.
   PubMed Web of Science ®Google Scholar
• GIBSON, G. G. and SKETT, P., 1994,4 Factors affecting drug metabolism: internal factors. In Introduction to Drug Metabolism, edited by G. G. Gibson and P. Skett 2nd edn (London: Blackie Academic & Professional), pp. 114–120.
   Google Scholar
• GRANT, D. M., CAMPBELL, M. E., TANG, B. K. and KALO W., 1987, Biotransformation of caffeine by microsomes fro human liver. Biochemical Pharmacology, 36, 1251–1260.
   PubMed Web of Science ®Google Scholar
• IMAI, Y., Pro, A. and SATO, R., 1966, Evidence for biochemically different type of vesicles in the hepatic microsomal function. Journal of Biochemistry, 60, 417–438.
   PubMed Web of Science ®Google Scholar
• IMAOKA, S., FUJITA, S. and FUNAE, Y., 1991, Age-dependent expression of cytochrome P450s in rat liver. Biochemka et Biophysica Acta, 1097, 187–192.
   PubMed Web of Science ®Google Scholar
• KAMATAKI, T., KITADA, M., SHIGEMATSU, H. and KITAGAWA, H., 1979, The involvement of cytochrome P-448 and P-450 in NADH-dependent 0-demethylation ofp-nitroanisole in rat liver microsomes. Japanese Journal of Pharmacology, 29, 191–201.
   PubMedGoogle Scholar
• KATO, R. and YAMAZOE, Y., 1992, Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letters, 64/65, 661–667.
   Google Scholar
• KEARNS, G. L. and REED, M. D., 1989, Clinical pharmacokinetics in infants and children. Clinical Pharmacokinetics, 17 (suppl. 1), 29–67.
   PubMed Web of Science ®Google Scholar
• KURATA, N., NISHIMURA, Y., INABA, T., FISCHER, N., IwAsE, M. and YASUHARA, H., 1997, Estimation of the human hepatic microsomal cytochrome P-450 species responsible to the trimethadione metabolism. Japanese Journal of Pharmacology, 73, 115.
   Google Scholar
• MILSAP, R. L. and JusKo, W. J., 1994, Pharmacokinetics in the infant. Environmental Health Perspectives, 102 (suppl. 11), 107–110.
   PubMed Web of Science ®Google Scholar
• NAKAMURA, M., TANAKA, E., MISAWA, S., SHIMADA, T., IMAOKA, S. and FUNAE, Y., 1994, Trimethadione metabolism, a useful indicator for assessing hepatic drug-oxidizing capacity. Biochemical Pharmacology, 47, 247–251.
   PubMed Web of Science ®Google Scholar
• NASH, T., 1953, The colorimetric estimation of formaldehyde by means the Hantzsh reaction. Biochemical Journal, 55, 416–421.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide binding pigment of liver microsomes, I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• RATANASAVANH, D., BEAUNE, P., MOREL, F., FLINOIS, J.-P., GUENGERICH, F.-P. and GUILLOUZO, A., 1991, Intraloubular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology, 13, 1142–1151.
   Google Scholar
• SAKAMOTO, K., KIRITA, S., BABA, T., NAKAMURA, Y., YAMAZOE, Y., KATO, R., TAKANAKA, A. and MATSUBARA, T., 1995, A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization. Archives of Biochemistry and Biophysics, 319, 372–382.
   PubMed Web of Science ®Google Scholar
• SCHMUCKER, D. L., 1985, Aging and drug disposition: an update. Pharmacological Reviews, 37, 133–148.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., MIMURA, M., INOUE, K., NAKAMURA, S., ODA, H., OHOMORI, S. and YAMAZAKI, H., 1997a, Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Archives of Toxicology, 71, 401–408.
   PubMed Web of Science ®Google Scholar
• SHIMADA, M., MURAYAMA, N., NAGATA, K., HASHIMOTO, H., ISHIKAWA, H. and YAMAZOE, Y., 1997b, A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: reversal of the profiles by growth hormone-treatment. Archives of Biochemistry and Biophysics, 337, 34–42.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. and GUENGERICH, F. P., 1994, Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacoogy and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MIMURA, M., WAKAMIYA, N., UENG, Y.-F., GUENGERICH, F. P. and INUI Y. 1996, Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal livers and adult lungs. Drug Metabolism and Disposition, 24, 515–522.
   Google Scholar
• TANAKA, E., 1992, Simultaneous determination of caffeine and its primary demethylated metabolites in human plasma by high-performance liquid chromatography. Journal of Chromatography, Biomedical Application, 575, 311–314.
   PubMed Web of Science ®Google Scholar
• TANAKA, E., ISHIKAWA, A., ABEI, M., and KOBAYASHI, S., 1997, Trimethadione metabolism as a probe drug to estimate hepatic oxiding capacity in human. Comparative Biochemistry and Physiology, 115C, 211–216.
   Google Scholar
• TANAKA, E., ISHIKAWA, A., KOBAYASHI, S., YASUHARA, H., MisAwA, S. and KUROIWA, Y., 1993, Mini-review: Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats. Comparative Biochemistry and Physiology, 104C, 205–207.
   Google Scholar
• TANAKA, E., ISHIKAWA, A., YAMAMOTO, Y., FUKAO, K., IWASAKI, Y. and MISAWA, S., 1989, The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction. Journal of Pharmaco-Dynamics, 12, 145–148.
   PubMedGoogle Scholar
• TANAKA, E., IsHIKAwA, A., YAMAMOTO, Y., OSADA, A., TSUJI, K., FUKAO, K., MISAWA, S. and IWASAKI, Y., 1992, A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. International Journal of Clinical Pharmacology Therapy and Toxicology, 30, 336–341.
   PubMed Web of Science ®Google Scholar
• TANAKA, E., and MISAWA, S., 1992, Improved method for the determination of trimethadione and its demethylated metabolite, dimethadione, in human serum by gas chromatography. Journal of Chromatography, Biomedical Application, 584, 267–269.
   PubMed Web of Science ®Google Scholar
• TANAKA, E., SAKAMOTO, N., INususm, M. and MISAWA, S., 1995, The simultaneous determination of plasma phenytoin and its primary hydroxylated metabolites in carbon tetrachloride-intoxicated rats by high-performance liquid chromatography. Journal of Chromatography, Biomedical Applications, 673, 147–151.
   Web of Science ®Google Scholar
• WOODHOUSE, K. and WYNNE, H. A., 1992, Age-related changes in hepatic function. Drugs and Aging, 2, 243–252.
   PubMed Web of Science ®Google Scholar
• YAMAZAKI, H., HOROKI, S., URANO, T., INouE, K. and SHIMADA, T., 1996, Effects of roxithromycin, erythromycin and troleandmycin on their N-demethylation by rat and human cytochrome P450 enzyme. Xenobiotka, 26, 1143–1153.
   PubMed Web of Science ®Google Scholar